Source: Pharmacogenomics. Unidade: FMRP
Subjects: FARMACOGENÉTICA, HIPERTENSÃO NA GRAVIDEZ, PRÉ-ECLÂMPSIA, HIPERTENSÃO, POLIMORFISMO, GENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo R et al. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, v. 18, n. 6, p. 571-583, 2017Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0198. Acesso em: 09 out. 2024.APA
Luizon, M. R., Palei, A. C. T., Cavalli, R. de C., & Sandrim, V. C. (2017). Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives. Pharmacogenomics, 18( 6), 571-583. doi:10.2217/pgs-2016-0198NLM
Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 out. 09 ] Available from: https://doi.org/10.2217/pgs-2016-0198Vancouver
Luizon MR, Palei ACT, Cavalli R de C, Sandrim VC. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives [Internet]. Pharmacogenomics. 2017 ; 18( 6): 571-583.[citado 2024 out. 09 ] Available from: https://doi.org/10.2217/pgs-2016-0198